GlaxoSmithKline (GSK) is set to apply artificial intelligence (AI) technology to improve its drug discovery efforts through a collaboration with Cloud Pharmaceuticals.
Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI).
The 13th annual ADMET conference is returning to London, UK for an in-depth exploration of the optimisation of ADMET modelling techniques, preclinical DMPK applications and the development of bioph
BenevolentAI and a group of UK sight loss charities have launched a new partnership to use the firm’s AI-powered drug discovery to find treatments and a potential cure for age-related macul
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
